GL1X · GenesisL1 explorer

MolNFT v1 · #14141 · protein

Structural changes of the active site cleft and different saccharide binding modes in human lysozyme co-crystallized with hexa-N-acetyl- chitohexaose at pH 4.0

1LZS: “Structural changes of the active site cleft and different saccharide binding modes in human lysozyme…”. X-ray diffraction, 2 ligands (NAG, NA), 3 pockets (best druggability 0.53). MolNFT v1 #14141 on GenesisL1: 3D structure, binding…

PDB
1LZS
Type
protein
Length
260 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human lysozyme
EC
3.2.1.17
UniProt
P00695
Ligands
NAG, NA
Pockets
3 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHuman lysozyme (EC 3.2.1.17)protein13038% helix, 12% strandP00695

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11120.530.8231empty
2770.360.7617NAG
3690.330.7617NAG

Interfaces

1 interface between chains.

  • A–B · 393 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 1LZS · Structural changes of the active site cleft and different saccharide binding modes in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.